Frazier Life Sciences
Biotech investment firm with venture and public strategies partnering with and building companies developing novel therapeutics.
Palo Alto, United States · 38+ investments · 126 portfolio companies
- Headquarters
- Palo Alto, United States
- Founded
- 2015
- Website
- frazierls.com
- AUM
- $4.3B
- Portfolio Companies
- 126
- Total Investments
- 38
- Last Investment
- Jul 2026
- Geographic Focus
- United States, Europe
Investment Thesis
Frazier Life Sciences is a Venture Capital firm based in Palo Alto, United States. It has made 38 investments in Biotech and Life Sciences, including Amunix Pharmaceuticals, Callio Therapeutics and Syneron Bio.
Portfolio126
.jpg)
Co-investors24
Sign up to view co-investors
24 co-investors across 206 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×18 · Hedge Fund ×3 · Corporate VC ×2 · 66 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/frazier-life-sciences"><img src="https://indexed.vc/api/badge/investor/frazier-life-sciences" alt="Frazier Life Sciences on Indexed.vc" width="260" height="76" /></a>